Clinical trials
Phase 1/2 Carcinoid Tumor trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arbutus Biopharma Corporation | 1 |
| Hutchmed | 1 |
| National Cancer Institute (NCI) | 1 |
| Ochsner Health System | 1 |
| Sue O'Dorisio | 1 |
| University of California, San Francisco | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoid Tumor | 6 |
| Neuroendocrine Tumors | 5 |
| Neoplasms | 2 |
| Neuroblastoma | 2 |
| Adenoma, Islet Cell | 1 |
| Adrenocortical Carcinoma | 1 |
| Apudoma | 1 |
| Carcinoma, Neuroendocrine | 1 |
| Hodgkin Disease | 1 |
| Lymphoma, Non-Hodgkin | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.